OCL-2A3 compositions and uses thereof
US8067557B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 13, 2006 |
| Grant date | Nov 29, 2011 |
| Priority date | — |
| Expiry date | Sep 13, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/178
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention relates to osteoclast-specific genes and proteins. Specifically, the invention relates to OCL-2A3 or Atp6v0d2, the gene encoding it and uses thereof in methods and treatment of bone disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.